| Literature DB >> 28545445 |
Valérie Chalansonnet1,2,3,4,5,6, Claire Mercier7,8,9,10,11,12, Sylvain Orenga7, Christophe Gilbert8,9,10,11,12.
Abstract
BACKGROUND: Nitroreductases, NAD(P)H dependent flavoenzymes, are found in most of bacterial species. Even if Enterococcus faecalis strains seems to present such activity because of their sensitivity to nitrofurans, no enzyme has been described. Nitroreductases were separated of others reductases due to their capacity to reduce nitro compounds. They are further classified based on their preference in cofactor: NADH and/or NADPH. However, recently, azoreductases have been studied for their strong activity on nitro compounds, especially nitro pro-drugs. This result suggests a crossing in azo and nitro reductase activities. For the moment, no nitroreductase was demonstrated to possess azoreductase activity. But due to sequence divergence and activity specificity linked to substrates, activity prediction is not evident and biochemical characterisation remains necessary. Identifying enzymes active on these two classes of compounds: azo and nitro is of interest to consider a common physiological role.Entities:
Keywords: Azoreductases; Enterococcus faecalis; Nitroreductases
Mesh:
Substances:
Year: 2017 PMID: 28545445 PMCID: PMC5445473 DOI: 10.1186/s12866-017-1033-3
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Strains used in the study
| Species | Collections | Code | Number |
|---|---|---|---|
|
| bioMérieux | EC | 76.10.041 |
|
| bioMérieux | EF1 | 80.04.017 |
|
| bioMérieux – ATCC29212 | EF2 | 83.11.066 |
|
| bioMérieux | EF3 | 95.01.009 |
|
| bioMérieux | EF4 | 98.06.158 |
|
| bioMérieux | EF5 | 00.08.222 |
|
| bioMérieux | EF6 | 04.05.001 |
|
| bioMérieux | EF7 | 07.06.031 |
|
| bioMérieux – ATCC700802 | V583 | 95.07.074 |
|
| bioMérieux – Stratagene | XL1Blue | 13.02.209 |
Plasmids constructed for the study
| Name | Cloned gene | DNA extracted from |
|---|---|---|
| pQE30-azoA95 |
|
|
| pQE30-EF0404 |
|
|
| pQE30-EF0648 |
|
|
| pQE30-EF0655 |
|
|
| pQE30-EF1181 |
|
|
Primers used for amplification and cloning of ef0404, ef0648, ef0655 and ef1181 in pQE30 plasmid
| Targeted gene | Primers | Tm (°C) | PCR amplicon |
|---|---|---|---|
|
| cgggatccTCAAAATTATTAGTTGTTAAAGCACATCC | 59.5 | 644 pb |
| acgcgtcgacATTTAGAATGTTTTACCGTATTCAGTTGC | 60.4 | ||
|
| cgggatccACAACATATACAACGAATGATTTTTCAG | 59.0 | 660 pb |
| acgcgtcgacTTTTATTGCCTATTCAAATGTCGTG | 59.5 | ||
|
| cgggatccATGTATCAAGATGTTGTTCGCAGC | 60.6 | 701 pb |
| acgcgtcgacCAATCACTTTGGATGTTTGTTCC | 58.6 | ||
|
| cgggatccTCAAAATTTACTGAAATGATGAAAAACC | 60.1 | 652 pb |
| acgcgtcgacGCTTTCACTCCTTTCCTCTTCG | 59.7 | ||
|
| cgggatccAATCAAACAATCGAACAATTACTAAGTC | 57.7 | 763 pb |
| acgcgtcgacCACGCTCTTTTGTTTAGACATC | 58.2 |
For each gene, primer couples are reported. Nucleotides identical to the gene sequence are in capital letters and nucleotide motifs required for cloning containing restriction sites BamHI or SalI are in lowercase
Fig. 1Nitroreductase activity of E. faecalis strains. Kinetics of reduction of 7NCCA by 8 different E. faecalis strains (EF) and one E. coli strain (EC) followed as variation of fluorescence intensity at 365/440 nm in relative fluorescence unit (RFU) over 24 h. E. coli strain is used as positive control for nitroreductase activity
Fig. 2Phylogeny of azoreductase and nitroreductase proteins. Phylogenic tree was generated using a multiple alignment of proteins (Muscle alignment) which have experimentally shown azoreductase and/or nitroreductase activity. Nitroreductases of E. faecalis, studied here, are indicated in bold. A specific colour is attributed to each reductases family. For azoreductases, families type 1 to 3 are indicated. In dark blue, type 1 gathers FMN-dependent NADH azoreductases. In orange, type 2 regroups FMN-dependent NADPH azoreductases. In turquoise, type 3 are FMN-independent azoreductases. For nitroreductases, in red, group A represents oxygen-insensitive NADPH dependent nitroreductase. In green, group B gathers oxygen-insensitive NAD(P)H nitroreductase. The nomenclature is the following: first the protein name and then the species. The references of the protein sequences aligned are the following: Azo1_S. aureus:AAT29034.1; AzoA_E. faecalis:AAR38851.1; AzoA_P. kullae:AAO39146.1; AzoB_X. azovorans:AAM92125.2; AzoB_P. kullae:ADD80733.1; AzoR_R. sphaeroides:ABA81336.1.; AzoR_E. coli:AAC74494.1.; AzoR_G. stearothermophilus:AAD24436.1.; AzoR1_P. putida:AAN68474.1.; AzoR1_P. aeruginosa:AAG04174.1; AzoR1_B. subtilis:CAB13815.1.; AzoR2_P. aeruginosa:AAG05350.1; AzoR2_B. subtilis:CAB15359.1.; AzoR3_P. aeruginosa:AAG06611.1.; AzR_B. subtilis:CAB12762.1.; EF0404_E. faecalis:AAO80264.1.; EF0648_E. faecalis:AAO80473.1.; EF0655_E. faecalis:AAO80478.1; EF1181_E. faecalis:AAO80980.1; Frase1_V. fisheri:BAA04595.2.; FRP_V. harveyi:AAA21331.1.; NfrA_S. aureus:ABD29532.1.; NfrA1_B. subtilis:CAB15837.1.; NfsA_K. pneumoniae:ABR76318.1.; NfsA_E. coli:AAC73938.1.; NfsB_P. aeruginosa:AAG08575.1.; NfsB_E. coli:AAC73679.1.; NfsB_K. pneumoniae:ABR76003.1.; NtrA_S. aureus:ABD29959.1.; PnbA_L. plantarum:CCC77618.1.; PnrA_P. putida:AAM95986.1.; PnrB_P. putida:AAM95987.1.; SnrA_S. typhimurium:AAD18027.1.; YcnD_B. subtilis:BAA09018.1.; YdgI_B. cereus:AAP09971.1.; YdgI_B. subtilis:BAA19399.1.; YfkO_B. cereus:AAP08598.1.; YfkO_B. licheniformis:EWH23016.1.; YtjD_L. lactis:AAK06011.1.; NQO1_H. sapiens:AAB60701.1
Fig. 3Nitroreductase activity of AzoA, EF0404, EF0648, EF0655, EF1181: native (a) and without prosthetic group enzymes (b). Nitroreductase activity is evaluated by following fluorescence intensity at 365/440 nm during 900 min in presence of 100 μmol.l−1 7NCCA, 500 μmol.l−1 NADPH and 10 mg.l−1 of indicated enzyme. a The proteins used were purified with their prosthetic group in their native form. No FMN was added for the reaction. b The proteins used were purified without their prosthetic group, that is purified using the denaturing/renaturing protocol. The reduction is followed without addition of FMN (−) and with 5 μmol.l−1 of FMN (− •)
Fig. 4Nitroreductase activity of AzoA, EF0404, EF0648, EF0655, EF1181 and their cofactor preferences. a-b The proteins used were purified without their prosthetic group, that is purified using the denaturing/renaturing protocol. Nitroreductase activity is evaluated by following fluorescence intensity at 365/440 nm during 900 min in presence of 100 μmol.l−1 7NCCA and 10 mg.l−1 of indicated enzyme. To determine each enzyme preference toward cofactors, 7NCCA reduction is followed in presence of 500 μmol.l−1 NADPH (• • •) or NADH (− −). FMN is added at 5 μmol.l−1. The control wells contained the reaction buffer (7NCCA, FMN, NAD (P) H) without enzyme
Fig. 5Azoreductase activity of AzoA and EF0404 and their cofactor preferences. The proteins used were purified without their prosthetic group, that is purified using the denaturation/renaturation protocol. For the enzymes presenting azoreductase activity, methyl red reduction is monitored by fluorescence intensity at 250/395 nm during 60 min in presence 10 mg.l−1 of indicated enzyme. a To test the importance of FMN for these enzymes, methyl red (100 μmol.l−1) reduction is followed without addition of FMN (−) and with 5 μmol.l−1 of FMN (− •). NADPH is added at 500 μmol.l−1. b Methyl red (100 μmol.l−1) reduction is followed in presence of 500 μmol.l−1. NADPH (• • •) or NADH (− −) to evaluate cofactors preference. FMN is added at 5 μmol.l−1. The control wells contained the reaction buffer (methyl red, FMN, NAD (P) H) without enzyme
Summary of purified proteins activities
| Enzymes families | Reductase activity | FMN-dependence | NADPH | NADH | |
|---|---|---|---|---|---|
| AzoA | Type 1: FMN-dependent NADH azoreductase | Azo + | + | + | ++ |
| Nitro + | + | ++ | + | ||
| EF0404 | Group B: FMN-dependent | Azo + | + | + | ++ |
| Nitro + | + | ++ | + | ||
| EF0648 | Group B: FMN-dependent |
|
|
|
|
| Nitro + | + | + | + | ||
| EF0655 | FMN-dependent |
|
|
|
|
| Nitro + | + | + | + | ||
| EF1181 | Group A: FMN-dependent |
|
|
|
|
| Nitro + | + | ++ | − |
For each enzyme, it is reported whether it presents nitroreductase and/or azoreductase activity: +: Activity has been established by reduction of tested compound; −: No activity was observed; NA: not applicable
When activity was established, FMN-dependence and cofactor dependence/preference are indicated